Evofem bio news
WebMay 21, 2024 · Evofem Biosciences, Inc. May 21, 2024, 06:50 ET. SAN DIEGO, May 21, 2024 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced the closing of its previously announced ...
Evofem bio news
Did you know?
WebEvofem Clocks 42% Growth For Its On-Demand Birth Control Product. Evofem Biosciences Inc's (NASDAQ: EVFM) Q2 Phexxi sales increased 42% Y/Y to $6.0 million, reflecting higher ex-factory sales and lower gross-to-net adjustments of 40%. The company's operating expense was reduced by 8% to $30 million and improved loss from operations by 16% to ... WebEvofem Biosciences, Inc., (OTCQB: EVFM) is a commercial-stage biopharmaceutical company committed... 12400 High Bluff Dr, San Diego, CA 92130
Web12400 High Bluff Drive, Suite 600 San Diego, California 92130 1.858.550.1900 WebApr 11, 2024 · Evofem Biosciences Enters into Financing Agreement for up to $80 Million, Closes First Tranche of Strategic Investment from PDL BioPharma Financing to fund pre-launch commercialization activities ...
WebEvofem Biosciences Inc. 12400 High Bluff Drive. Suite 600. San Diego, California 92130. Phone 1 858 550-1900. Industry Pharmaceuticals. Sector Health Care/Life Sciences. Fiscal Year-end 12/2024 ... WebOct 12, 2024 · A biotech with an approved non-hormonal birth control gel had hoped it would be at the FDA's doorsteps in early 2024 to request a label expansion into STI prevention. But those ambitions were ...
WebMay 7, 2024 · Evofem Biosciences, Inc. (OTCQB:EVFM) Q1 2024 Earnings Conference Call May 6, 2024 4:30 PM ETCompany ParticipantsAmy Raskopf - Vice President of Investor RelationsSaundra Pelletier - Chief...
WebMay 4, 2024 · SAN DIEGO, May 4, 2024 /PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) ("Evofem" or the "Company"), today reported financial results for the three-month period ended March 31, 2024. "The impact of our disciplined fiscal approach has yielded another quarter of solid performance for Evofem," said Saundra Pelletier, Chief … tasteful treasures toysWebApr 5, 2024 · Evofem Biosciences GAAP EPS of -$0.33 misses by $0.10, revenue of $3.57M beats by $0.21M. SA NewsThu, Mar. 03, 2024. the bureau orlando flWebEvofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual … the bureau tv castWebNews. Press Releases. Research Reports. SEC Filings. Benzinga. Evofem Clocks 42% Growth For Its On-Demand Birth Control Product. Evofem Biosciences Inc's (NASDAQ: … the bureau online sa prevodomWebSep 8, 2024 · SAN DIEGO, Sept. 8, 2024 /PRNewswire/ --Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced that Phexxi ™ (lactic acid, citric acid and potassium bitartrate), the first and only non-hormonal prescription vaginal gel is now available in the United States for the prevention of pregnancy in females of reproductive potential for use … the bureaus inc numberWebMar 25, 2024 · Evofem Biosciences (EVFM) has priced its public offering of ~17.1M common shares at $1.75/share, for expected gross proceeds of ~$30M.Underwriters' over-allotment is an additional... tastefuls salmon pate cat foodWebApr 24, 2024 · SAN DIEGO, April 24, 2024 /PRNewswire/ --Evofem Biosciences, Inc. (NASDAQ: EVFM), a clinical-stage biopharmaceutical company, today announced that three new data sets from the Company's Phase 3 AMPOWER trial evaluating Phexxi™, a first-in-class investigational Multipurpose Vaginal pH Regulator (MVP-R™) for the prevention of … tasteful tattoos for women over 50